Evidence map›Paper›PMID 35680568›Full record

ArticleAging2022

ZhenQi FuZheng formula inhibits the growth of colorectal tumors by modulating intestinal microflora-mediated immune function.

Weiqi Meng, Zhiping Li, Yiting Zhang, Anhui Yang, Yanzhen Wang, Yulin Zhou, Wanyue Wu, Ye Qiu, Lanzhou Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. From gut to proteomics: the impact ofFrontiers in oncology · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Weiqi MengSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Zhiping LiDepartment of Clinical Pharmacy, The First Hospital of Jilin University, Jilin University, Changchun, Jilin, P.R. China.
Yiting ZhangSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Anhui YangSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Yanzhen WangSchool of Pharmacy and Food Science, Zhuhai College of Science and Technology, Zhuhai, P.R. China.
Yulin ZhouSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Wanyue WuSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Ye QiuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, P.R. China.
Lanzhou LiSchool of Life Sciences, Jilin University, Changchun, Jilin, P.R. China.
Jilin University · CNChangchun University of Chinese Medicine · CNFirst Hospital of Jilin University · CNZhuhai Institute of Advanced Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zhenqi Fuzheng formula (ZQFZ), of which the main ingredients are

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeAnimalsCytokinesImmunityMiceNF-kappa BCytokinesNF-kappa Bcolorectal cancerimmunomodulatoryintestinal microfloraT cellsZhenqi Fuzheng formula

Identifiers

PMID35680568
PMCPMC9217701
OpenAlexW4282922753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.